MedPath

Role of zinc supplemenation on height of thalassemia patients.

Phase 3
Conditions
Health Condition 1: D758- Other specified diseases of bloodand blood-forming organsHealth Condition 2: D758- Other specified diseases of bloodand blood-forming organs
Registration Number
CTRI/2023/04/052086
Lead Sponsor
Motilal Nehru Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Transfusion dependent thalassemia Patients in age group (1-10years) 2)Height <50th centile as per WHO and IAP combined growth charts

Exclusion Criteria

1)Height >50th centile 2)Thalassemia patients who are known case of chronic disorders affecting growth (CKD/CLD/hypersplenism/hypothyroidism)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath